Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2025)

Eton Pharmaceuticals has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $19000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $19000.0, up 58.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $19000.0 (up 58.33% YoY), and the FY2025 annual result was $19000.0, up 58.33% from the prior year.
• Other Non-Current Assets came in at $19000.0 for Q4 2025 at Eton Pharmaceuticals, roughly flat from $19000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $36000.0 in Q1 2021 to a low of $12000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $12000.0 (2022), against an average of $15900.0.
• Across the five-year window, Other Non-Current Assets sank 71.6% in 2021 and soared 58.33% in 2025, its largest moves.
• Eton Pharmaceuticals' Other Non-Current Assets stood at $21000.0 in 2021, then plunged by 42.86% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then jumped by 58.33% to $19000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $19000.0 (Q4 2025), $19000.0 (Q3 2025), and $12000.0 (Q2 2025), per Business Quant data.